IRIS Accounts Production v24.3.0.553 08001193 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080011932023-03-31080011932024-03-31080011932023-04-012024-03-31080011932022-03-31080011932022-04-012023-03-31080011932023-03-3108001193ns15:EnglandWales2023-04-012024-03-3108001193ns14:PoundSterling2023-04-012024-03-3108001193ns10:Director12023-04-012024-03-3108001193ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108001193ns10:SmallEntities2023-04-012024-03-3108001193ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108001193ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108001193ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108001193ns10:FullAccounts2023-04-012024-03-3108001193ns10:OrdinaryShareClass22023-04-012024-03-3108001193ns10:OrdinaryShareClass32023-04-012024-03-3108001193ns10:OrdinaryShareClass42023-04-012024-03-3108001193ns10:OrdinaryShareClass52023-04-012024-03-3108001193ns10:Director22023-04-012024-03-3108001193ns10:RegisteredOffice2023-04-012024-03-3108001193ns5:CurrentFinancialInstruments2024-03-3108001193ns5:CurrentFinancialInstruments2023-03-3108001193ns5:ShareCapital2024-03-3108001193ns5:ShareCapital2023-03-3108001193ns5:RetainedEarningsAccumulatedLosses2024-03-3108001193ns5:RetainedEarningsAccumulatedLosses2023-03-3108001193ns5:MotorVehicles2023-04-012024-03-3108001193ns5:ComputerEquipment2023-04-012024-03-3108001193ns5:MotorVehicles2023-03-3108001193ns5:ComputerEquipment2023-03-3108001193ns5:MotorVehicles2024-03-3108001193ns5:ComputerEquipment2024-03-3108001193ns5:MotorVehicles2023-03-3108001193ns5:ComputerEquipment2023-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108001193ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3108001193ns5:CurrentFinancialInstruments2023-04-012024-03-3108001193ns5:DeferredTaxation2023-03-3108001193ns5:DeferredTaxation2023-04-012024-03-3108001193ns5:DeferredTaxation2024-03-3108001193ns10:OrdinaryShareClass22024-03-3108001193ns10:OrdinaryShareClass32024-03-3108001193ns10:OrdinaryShareClass42024-03-3108001193ns10:OrdinaryShareClass52024-03-31080011931ns10:Director12023-03-31080011931ns10:Director12022-03-31080011931ns10:Director12023-04-012024-03-31080011931ns10:Director12022-04-012023-03-31080011931ns10:Director12024-03-31080011931ns10:Director12023-03-31
REGISTERED NUMBER: 08001193 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2024

FOR

WHEELER SCIENCE MEDICINE & EDUCATION LTD

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WHEELER SCIENCE MEDICINE & EDUCATION LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2024







DIRECTORS: D W Wheeler
S J Wheeler





REGISTERED OFFICE: 10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA





BUSINESS ADDRESS: Heatherlea
Carnoch
Glencoe
Bellachulish
Argyll
PH49 4HQ





REGISTERED NUMBER: 08001193 (England and Wales)





ACCOUNTANTS: Thompson Taraz Rand Ltd
Chartered Accountants
10 Jesus Lane
Cambridge
Cambridgeshire
CB5 8BA

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET
31ST MARCH 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 36,297 46,214

CURRENT ASSETS
Debtors 6 80,396 65,385
Cash at bank 39,286 50,929
119,682 116,314
CREDITORS
Amounts falling due within one year 7 (29,672 ) (36,676 )
NET CURRENT ASSETS 90,010 79,638
TOTAL ASSETS LESS CURRENT LIABILITIES 126,307 125,852

PROVISIONS FOR LIABILITIES 10 (9,074 ) (8,781 )
NET ASSETS 117,233 117,071

CAPITAL AND RESERVES
Called up share capital 11 100 100
Retained earnings 117,133 116,971
SHAREHOLDERS' FUNDS 117,233 117,071

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

BALANCE SHEET - continued
31ST MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20th November 2024 and were signed on its behalf by:





D W Wheeler - Director


WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2024

1. STATUTORY INFORMATION

Wheeler Science Medicine & Education Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover shown in the profit and loss account represents the invoiced sales in relation to the provision of medical consultancy services.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Motor vehicles - 25% on reducing balance
Equipment - 33.33% on cost

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any.

Financial instruments
Basic financial assets and basic financial liabilities as defined under section 11 of FRS 102, including trade and other debtors, trade and other creditors, cash and bank balances and investments in commercial paper, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 5 ) .

5. TANGIBLE FIXED ASSETS
Motor
vehicles Equipment Totals
£    £    £   
COST
At 1st April 2023 74,318 26,376 100,694
Additions - 2,905 2,905
Disposals - (12,641 ) (12,641 )
At 31st March 2024 74,318 16,640 90,958
DEPRECIATION
At 1st April 2023 34,599 19,881 54,480
Charge for year 9,930 2,442 12,372
Eliminated on disposal - (12,191 ) (12,191 )
At 31st March 2024 44,529 10,132 54,661
NET BOOK VALUE
At 31st March 2024 29,789 6,508 36,297
At 31st March 2023 39,719 6,495 46,214


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 71,089 62,106
Other debtors 5,921 3,279
Directors' current accounts 3,386 -
80,396 65,385

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts (see note 8) - 3,225
Trade creditors - 658
Corporation tax 10,418 12,145
Social security and other taxes 155 330
VAT 17,602 14,888
Directors' current accounts - 3,977
Accrued expenses 1,497 1,453
29,672 36,676

The directors' current accounts are repayable on demand and interest free.

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024

8. LEASING AGREEMENTS

Assets held under finance leases, which are leases where substantially all the risks and rewards of ownership have passed to the company, are capitalised in the balance sheet as a tangible fixed asset and are depreciated over the shorter of the lease term and their useful lives. The capital elements of future obligations under the leases are included as liabilities in the balance sheet. The interest element of the rental obligation is charged to the profit and loss account.

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Hire purchase contracts - 3,225

Liabilities held under hire purchase agreements are secured against the asset to which they relate.

10. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 9,074 8,781

Deferred
tax
£   
Balance at 1st April 2023 8,781
Provided during year 293
Charge for the year
Balance at 31st March 2024 9,074

The provision for deferred taxation is made up of accelerated capital allowances.

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
55 Ordinary A £1 55 55
30 Ordinary B £1 30 30
5 Ordinary C £1 5 5
5 Ordinary D £1 5 5
5 Ordinary E £1 5 5
100 100

WHEELER SCIENCE MEDICINE & EDUCATION LTD (REGISTERED NUMBER: 08001193)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2024

12. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st March 2024 and 31st March 2023:

2024 2023
£    £   
D W Wheeler
Balance outstanding at start of year - -
Amounts advanced 3,386 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 3,386 -

13. RELATED PARTY DISCLOSURES

At the balance sheet date, the director had an outstanding director's loan account balance of £3,386 which is disclosed in other debtors.

The loan is interest free and repayable on demand.